COVID-19 vaccination becomes much easier as pvt hospitals, labs, pharmacy chains reach customers. Rajesh Murthy * who lives in one of the largest gateways communities in Bannerghatta in Bangalore has received his second dose of COVID-19 vaccine on the premises of his apartment.
“In the past, we had to go to the hospital and wait in line for the first dose. At the moment, it’s smooth and easy, ”said Murthy.
Murthy found out about his ignorance in a vaccination campaign by Apollo Hospitals, Bannerghatta.
Apollo Hospitals has been working closely with apartment organizations and welfare organizations in Bangladuru, Hyderabad, Navi Mumbai and other COVID-19 vaccine management cities.
Apollo, on May 27, said it had completed 1 million vaccinations in 80 areas in India. It plans to make a million a week in June and double that in July.
“We are in the process of completing 20 million jabs by September 2021,” said Shobana Kamineni, Deputy Executive Chairman, Apollo Group of Hospitals, recently.
Also read : PhonePe affects a record 300 registered lifetime users
The Union government has released the purchase of COVID-19 vaccine from May 1 by allowing private hospitals and companies to purchase vaccines directly from manufacturers and distribute them to the public.
The Serum Institute of India (SII) and Barat Biotech have set the price of their vaccines, Covishield and Coxinxin, at Rs 600 and Rs 1,200, respectively. Dr. Reddy’s has set the price of Sputnik V for $ 995 per dose, including GST.
There is no administration fee
Although there is no charge for the hospital as administrative fees, major private hospitals charge between Rs 200 and Rs 300 in addition to the cost of purchasing the vaccine.
For onsite vaccinations, hospitals charge an additional Rs 200 – Rs 300 per dose, but people, especially the elderly, who cannot go to immunization centers or who find it difficult to use the CoWIN platform, pay little attention to the price due to on-site immunization.
Some hospitals have started vaccination with cars, while others are considering vaccinating people in their homes. However, there are dangers in both.
Karnataka also allows diagnostic chains
Currently, the provinces only allow private hospitals to make inococations. But Karnataka allowed even diagnostic chains such as Metropolis to perform inoculation through camps and vaccination centers.
“We are already offering a vaccine in Bangaluru; it is a government decision. Most provinces only allow hospitals. Karnataka has allowed certain diagnostic laboratories. They have given us permission,” said Metropolis CEO Ameera Shah.
“Currently, no vaccine will be available. It will be available next month or so. We are in talks with the manufacturers to get the drugs directly. We have 2,500 facilities and capacity for homework. said Shah.
Even pharmacies like Pharmeasy, 1 mg, and Practo, among others, have plans to start vaccinating COVID-19.
Although many states do not allow home immunizations due to concerns about vaccination, delays in accessing a clinic in the event of an adverse event and the challenges of maintaining a 30-minute adherence regimen poses a problem for many.
Also read : Infosys Insider Trading: Sebi bar 8 units from the stock market, a fine of Rs 3.06 crore
Business case
For at least the next two years, the COVID-19 vaccine is expected to be an important source of funding for private hospitals. Moneycontrol learns that a private hospital can make anywhere between Rs 150 – Rs 200 per vaccine. According to an April 21 statement from Jefferies India, private policies could raise up to $ 1.4 billion in revenue from FY22.
Max Healthcare, which makes 40,000-50,000 goals a day, is excited about this opportunity.
“There are good opportunities in terms of revenue and profit, just because the private health sector is allowed to charge what you want,” Abhay Soi, Chairman and Managing Director, Max Hospitals, told the company’s profit line.
“After this opportunity, we have a lot of conversations, antibody tests and so on. The size of the opportunity I believe is enormous. Only limited number of vaccines available. The situation is expected to improve in the next few weeks, “Soyi said.
Soy said the influx of more private stakeholders would reduce administrative costs.
Also read : Buy Gulf Oil Lubricants India; targeted at Rs 1000: Emkay Global Financial
